Sequences

Sample result

SIINFEKL, an exact peptide

A saved result, shown read-only. Sign in to run your own searches. A new account gets a free 30-day trial.

Patents

2,028 publications in 1,357 families match these filters.

  1. JP 2023524874-A2023-06-13

    Composition of nanoparticles

    Life Science Inkubator Betriebs GmbH and Co KG

    Query Match 100.0%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

    Family of 2

    Grouped by a shared priority claim, EP 20174156.8.

  2. US 11680084-B22023-06-20

    Live-attenuated flaviruses with heterologous antigens

    KATHOLIEKE UNIVERSITEIT LEUVEN

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 258 to 265. Positions start at 1 and include both ends.

    Query   1 SIINFEKL 8
              ||||||||
    Hit   258 SIINFEKL 265
    

    8 of 8 identical, no gaps.

  3. JP 2023526495-A2023-06-21

    SARS-COV-2 VACCINES

    GRITSTONE BIO INC

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 37 to 44. Positions start at 1 and include both ends.

    Query  1 SIINFEKL 8
             ||||||||
    Hit   37 SIINFEKL 44
    

    8 of 8 identical, no gaps.

  4. JP 2023526501-A2023-06-21

    Metal-Organic Frameworks Delivery Small Molecules and Biomacromolecules for Cancer Immunotherapy

    The University of Chicago,Wenbin Lin,Kaiyuan Ni,Taokun Luo,Guangxu Lan

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  5. COMBINATION THERAPY OF PD-1 AXIS BINDING ANTAGONISTS AND LRRK2 INHITIBORS

    F. HOFFMANN-LA ROCHE AG

    Query Match 100.0%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  6. US 11684671-B22023-06-27

    Enhancing the T-cell stimulatory capacity of human antigen presenting cells in vitro and in vivo and its use in vaccination

    VRIJE UNIVERSITEIT BRUSSEL

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  7. JP 2023528071-A2023-07-03

    COMBINATION OF AN ATP-HYDROLYZING ENZYME AND AN IMMUNE CHECKPOINT MODULATOR AND USES THEREOF

    MV BioTherapeutics SA

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 258 to 265. Positions start at 1 and include both ends.

    Query   1 SIINFEKL 8
              ||||||||
    Hit   258 SIINFEKL 265
    

    8 of 8 identical, no gaps.

  8. JP 2023528462-A2023-07-04

    NANOBODY (VHH) CONJUGATES AND USES THERE OF

    Children's Medical Center Corporation

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 9 to 16. Positions start at 1 and include both ends.

    Query  1 SIINFEKL 8
             ||||||||
    Hit    9 SIINFEKL 16
    

    8 of 8 identical, no gaps.

  9. US 11690910-B22023-07-04

    Pharmaceutical composition comprising a polymeric carrier cargo complex and at least one protein or peptide antigen

    CureVac SE

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 258 to 265. Positions start at 1 and include both ends.

    Query   1 SIINFEKL 8
              ||||||||
    Hit   258 SIINFEKL 265
    

    8 of 8 identical, no gaps.

  10. JP 2023529065-A2023-07-07

    Composition of nanoparticles as carrier for HPV-derived immunogenic fragments

    Life Science Inkubator Betriebs GmbH and Co KG, Deutsches Krebsforschungszentrum Stiftung des offentlichen Rechtes

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  11. US 11696943-B22023-07-11

    Self-antigen specific T-cells as vaccines for augmenting engraftment and stability of autologous transfer

    Vanderbilt University

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  12. US 11698375-B22023-07-11

    Method for producing an examination reagent and kit for analysing a T-cell frequency

    CONSTRUCTOR UNIVERSITY BREMEN GGMBH

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  13. HOMOLOGOUS ADENOVIRAL VACCINATION

    GRITSTONE BIO, INC

    Query Match 100.0%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 8, hit 37 to 44. Positions start at 1 and include both ends.

    Query  1 SIINFEKL 8
             ||||||||
    Hit   37 SIINFEKL 44
    

    8 of 8 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  14. JP 2023110035-A2023-08-08

    Peptide-based vaccines, methods of manufacturing, and uses thereof for inducing an immune response

    VACCITECH NORTH AMERICA, INC

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 20 to 27. Positions start at 1 and include both ends.

    Query  1 SIINFEKL 8
             ||||||||
    Hit   20 SIINFEKL 27
    

    8 of 8 identical, no gaps.

  15. JP 2023534232-A2023-08-08

    IMMUNOGENIC CONSTRUCTS, COMPOSITIONS, AND METHODS FOR INDUCING IMMUNE RESPONSE

    Oregon Health and Science University,PDX Pharmaceuticals Inc

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  16. EP 4223311-A12023-08-09

    INDIVIDUALIZED VACCINES FOR CANCER

    BIONTECH SE

    Query Match 100.0%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

    Family of 2

    Grouped by a shared priority claim, WO2011EP02576.

  17. METHODS AND MATERIALS FOR TREATING CANCER

    MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH

    Query Match 100.0%Identity 100.0%Family of 4

    Best alignment and family

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

    Family of 4

    Grouped by the same title and applicant. No priority claim is on record.

  18. US 11723950-B22023-08-15

    CAL-T constructs and uses thereof

    TRUSTEES OF BOSTON UNIVERSITY and THE GENERAL HOSPITAL CORPORATION

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  19. US 11723962-B22023-08-15

    Cell-based neoantigen vaccines and uses thereof

    Fred Hutchinson Cancer Center

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  20. US 11725034-B22023-08-15

    IL2 agonists and methods of use thereof

    Regeneron Pharmaceuticals, Inc.

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  21. JP 2023535727-A2023-08-21

    Compositions and Methods for Modulation of SIRPalpha-Mediated Signaling

    The Board of Trustees of the Leland Stanford Junior University

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  22. JP 2023538568-A2023-09-08

    LFA-1 signalling mediator for use in cancer therapy

    Universitaet Basel

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  23. VIRUS-INSPIRED COMPOSITIONS AND METHODS OF REDIRECTING PREEXISTING IMMUNE RESPONSES USING THE SAME FOR TREATMENT OF CANCER

    VerImmune Inc

    Query Match 100.0%Identity 100.0%Family of 3

    Best alignment and family

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

    Family of 3

    Grouped by the same title and applicant. No priority claim is on record.

  24. ADJUVANT COMPRISING A GLYCOARCHAEOL AND AN IMMUNOSTIMULANT

    National Research Council of Canada

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 6 to 13. Positions start at 1 and include both ends.

    Query  1 SIINFEKL 8
             ||||||||
    Hit    6 SIINFEKL 13
    

    8 of 8 identical, no gaps.

  25. US 11754561-B22023-09-12

    Functionalized biochips for SPR-MS coupling

    GENOPTICS, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE and UNIVERSITE D'EVRY VAL D'ESSONNE

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 258 to 265. Positions start at 1 and include both ends.

    Query   1 SIINFEKL 8
              ||||||||
    Hit   258 SIINFEKL 265
    

    8 of 8 identical, no gaps.

  26. COMPOSITIONS AND METHODS

    CHAIN BIOTECHNOLOGY LIMITED

    Query Match 100.0%Identity 100.0%Family of 3

    Best alignment and family

    Query 1 to 8, hit 18 to 25. Positions start at 1 and include both ends.

    Query  1 SIINFEKL 8
             ||||||||
    Hit   18 SIINFEKL 25
    

    8 of 8 identical, no gaps.

    Family of 3

    Grouped by the same title and applicant. No priority claim is on record.

  27. JP 2023539454-A2023-09-14

    IMMUNOSTIMULATORY BACTERIA-BASED VACCINES, THERAPEUTICS, AND RNA DELIVERY PLATFORMS

    Laura Hix Glickman,Bret Nicholas Peterson,Haixing Kehoe, Alexandre Charles Michel Iannello,Christopher D Thanos

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  28. JP 2023539525-A2023-09-14

    Antibody Therapy

    GENMAB A/S

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 18 to 25. Positions start at 1 and include both ends.

    Query  1 SIINFEKL 8
             ||||||||
    Hit   18 SIINFEKL 25
    

    8 of 8 identical, no gaps.

  29. MODIFIED ALPHAVIRUS VECTORS

    GRITSTONE BIO, INC

    Query Match 100.0%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 8, hit 37 to 44. Positions start at 1 and include both ends.

    Query  1 SIINFEKL 8
             ||||||||
    Hit   37 SIINFEKL 44
    

    8 of 8 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  30. US 11771761-B22023-10-03

    Adjuvant for animal and human vaccines

    WISCONSIN ALUMNI RESEARCH FOUNDATION

    Query Match 100.0%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  31. EP 4253546-A22023-10-04

    COMPLEX CONTAINING OLIGONUCLEOTIDE HAVING IMMUNOPOTENTIATING ACTIVITY AND USE THEREOF

    NAT INST BIOMEDICAL INNOVATION HEALTH & NUTRITION

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  32. JP 2023542492-A2023-10-10

    IMMUNOGENIC COMPOSITIONS AND USES THEREOF

    Flagship Pioneering Innovations VI LLC

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 258 to 265. Positions start at 1 and include both ends.

    Query   1 SIINFEKL 8
              ||||||||
    Hit   258 SIINFEKL 265
    

    8 of 8 identical, no gaps.

  33. JP 2023543554-A2023-10-17

    PeptiBAC Therapy

    Valo Therapeutics Oy

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 6 to 13. Positions start at 1 and include both ends.

    Query  1 SIINFEKL 8
             ||||||||
    Hit    6 SIINFEKL 13
    

    8 of 8 identical, no gaps.

  34. US 11793874-B22023-10-24

    Immunity-inducing agent and pharmaceutical composition containing same

    The University of Kitakyushu

    Query Match 100.0%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  35. EP 4265631-A22023-10-25

    LIVE-ATTENUATED FLAVIRUSES WITH HETEROLOGOUS ANTIGENS

    KATHOLIEKE UNIV LEUVEN KU LEUVEN RESEARCH & DEVELOPMENT

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 258 to 265. Positions start at 1 and include both ends.

    Query   1 SIINFEKL 8
              ||||||||
    Hit   258 SIINFEKL 265
    

    8 of 8 identical, no gaps.

  36. JP 2023545178-A2023-10-26

    COMBINATION OF A STING AGONIST AND A COMPLEX COMPRISING A CELL PENETRATING PEPTIDE, A CARGO AND A TLR PEPTIDE AGONIST

    BOEHRINGER INGELHEIM INTERNATIONAL GmbH

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 114 to 121. Positions start at 1 and include both ends.

    Query   1 SIINFEKL 8
              ||||||||
    Hit   114 SIINFEKL 121
    

    8 of 8 identical, no gaps.

  37. Method for producing complex to which tumor-specific peptides are attached and pharmaceutical composition for inhibiting tumor growth comprising complex prepared therefrom

    Chungbuk National University Industry-Academic Cooperation Foundation

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  38. JP 2023160828-A2023-11-02

    Particles Encapsulating Fusion Proteins Containing Linked Epitopes

    Cour Pharmaceuticals Development Company, Inc

    Query Match 100.0%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  39. US 11813326-B22023-11-14

    Cell-associating immunologic adjuvants for treatment enhancement

    ACADEMIA SINICA

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  40. US 11813327-B22023-11-14

    Ii vaccine adjuvant

    UNIVERSITY OF COPENHAGEN

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  41. US 11814627-B22023-11-14

    Circular RNAs and their use in immunomodulation

    THE BOARD OF THE LELAND STANFORD JUNIOR UNIVERSITY and EMORY UNIVERSITY

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  42. US 11814679-B22023-11-14

    Interleukin-10 production of antigen-specific CD8+ T cells and methods of use of same

    Eli Lilly and Company

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  43. US 11820822-B22023-11-21

    Methods for sensitizing cancer cells to T cell-mediated killing by modulating molecular pathways

    DANA-FARBER CANCER INSTITUTE, INC.

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  44. TARGETING MULTIPLE T CELL TYPES USING SPHERICAL NUCLEIC ACID VACCINE ARCHITECTURE

    NORTHWESTERN UNIVERSITY

    Query Match 100.0%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  45. JP 2023552040-A2023-12-14

    VIRUS-INSPIRED COMPOSITIONS AND METHODS OF REDIRECTING PREEXISTING IMMUNE RESPONSES USING THE SAME FOR TREATMENT OF CANCER

    VERIMMUNE INC,Joshua Weiyuan WANG et al

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  46. COMPOSITIONS FOR PREPARING ANIMAL-FREE EGG-LIKE PRODUCTS

    CLARA FOODS CO

    Query Match 100.0%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 8, hit 309 to 316. Positions start at 1 and include both ends.

    Query   1 SIINFEKL 8
              ||||||||
    Hit   309 SIINFEKL 316
    

    8 of 8 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  47. US 11859207-B22024-01-02

    Artificial antigen-presenting cell prepared from HLA-null cell line by using multiplex CRISPR-CAS9 system and use thereof

    The Catholic Uiversity of Korea Industry-Academic Cooperation Foundation

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  48. EP 4299803-A22024-01-03

    MACROMOLECULE ANALYSIS EMPLOYING NUCLEIC ACID ENCODING

    ENCODIA INC

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 4 to 11. Positions start at 1 and include both ends.

    Query  1 SIINFEKL 8
             ||||||||
    Hit    4 SIINFEKL 11
    

    8 of 8 identical, no gaps.

  49. JP 2024500360-A2024-01-09

    Modulating Th1/Th2 immune response by administering two populations of polymersomes having an associated antigen and an associated adjuvant

    ACM Biolabs Pte Ltd

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 258 to 265. Positions start at 1 and include both ends.

    Query   1 SIINFEKL 8
              ||||||||
    Hit   258 SIINFEKL 265
    

    8 of 8 identical, no gaps.

  50. JP 2024500837-A2024-01-10

    BACTERIA-ENGINEERED TO ELICIT ANTIGEN-SPECIFIC T CELLS

    CHAN ZUCKERBERG BIOHUB INC, THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 38 to 45. Positions start at 1 and include both ends.

    Query  1 SIINFEKL 8
             ||||||||
    Hit   38 SIINFEKL 45
    

    8 of 8 identical, no gaps.